前往化源商城

Journal of medicinal and pharmaceutical chemistry 2010-02-11

Physicochemical space for optimum oral bioavailability: contribution of human intestinal absorption and first-pass elimination.

Manthena V S Varma, R Scott Obach, Charles Rotter, Howard R Miller, George Chang, Stefanus J Steyn, Ayman El-Kattan, Matthew D Troutman

文献索引:J. Med. Chem. 53 , 1098-108, (2010)

全文:HTML全文

摘要

Oral bioavailability (F) is a product of fraction absorbed (Fa), fraction escaping gut-wall elimination (Fg), and fraction escaping hepatic elimination (Fh). In this study, using a database comprised of Fa, Fg, Fh, and F values for 309 drugs in humans, an analysis of the interrelation of physicochemical properties and the individual parameters was carried out in order to define the physicochemical space for optimum human oral bioavailability. Trend analysis clearly indicated molecular weight (MW), ionization state, lipophilicity, polar descriptors, and free rotatable bonds (RB) influence bioavailability. These trends were due to a combination of effects of the properties on Fa and first-pass elimination (Fg and Fh). Higher MW significantly impacted Fa, while Fg and Fh decreased with increasing lipophilicity. Parabolic trends were observed for bioavailability with polar descriptors. Interestingly, RB has a negative effect on all three parameters, leading to its pronounced effect on bioavailability. In conclusion, physicochemical properties influence bioavailability with typically opposing effects on Fa and first-pass elimination. This analysis may provide a rational judgment on the physicochemical space to optimize oral bioavailability.

相关化合物

结构式 名称/CAS号 全部文献
氧氟沙星 结构式 氧氟沙星
CAS:82419-36-1
L-尼古丁 结构式 L-尼古丁
CAS:54-11-5
利福平 结构式 利福平
CAS:13292-46-1
沙丁胺醇 结构式 沙丁胺醇
CAS:18559-94-9
对乙酰氨基苯酚 结构式 对乙酰氨基苯酚
CAS:103-90-2
舒必利 结构式 舒必利
CAS:15676-16-1
红霉素 结构式 红霉素
CAS:114-07-8
磺胺嘧啶 结构式 磺胺嘧啶
CAS:68-35-9
环孢霉素A 结构式 环孢霉素A
CAS:59865-13-3
安替比林 结构式 安替比林
CAS:60-80-0